About the Fibrosarcoma Session
Fibrosarcoma is a rare, aggressive cancer originating in fibrous connective tissues, affecting both adults and children. Recent research has shed light on the genetic and molecular drivers of this malignancy, revealing critical mutations in the fibroblast growth factor receptor (FGFR) and other pathways that promote tumor growth. Cutting-edge treatments, including targeted therapies and immunotherapies, are being developed to improve patient outcomes. Enhanced diagnostic techniques, such as advanced imaging and precise biopsy methods, facilitate early detection, which is vital for effective treatment. Current clinical trials are focused on optimizing these innovative therapies, offering new hope for patients with fibrosarcoma.
Topics Covered in Fibrosarcoma
Infantile Form
Adult-Type Tumors
NTRK Gene Fusions
TRK Inhibitors
Herringbone Histology
Wide Surgical Excision
Related Scientific Sessions at CIOC 2027
Why Attend the Fibrosarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Fibrosarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Fibrosarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Fibrosarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Fibrosarcoma Conference 2027 — FAQs
What is the Fibrosarcoma track at CIOC 2027?
The Fibrosarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Fibrosarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Fibrosarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Fibrosarcoma are all welcome — whether presenting or attending.
Can I present my research in the Fibrosarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Fibrosarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Fibrosarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.